New Delhi: India’s drug regulator, the Drugs Controller General of India, has approved the Covid vaccine Sputnik V for emergency use. Sputnik V is the third coronavirus vaccine to be approved by India’s drug regulator, as the country experiences an ongoing increase in cases. In January, the FDA approved two vaccines: Covishield from the Serum Institute of India and Covaxin from Bharat Biotech. India has been the 60th country to approve the two-dose vaccine. The Russian Direct Investment Fund (RDIF) has signed agreements with five pharmaceutical companies to produce over 850 million doses per year. However, only a few doses